University of Oxford
Also known as: Balliol College Oxford | Centre for Clinical Vaccinology and Tropical Medicine, Churchill Hospital, Oxford, United Kingdom | Centre for Human Genetics, University of Oxford | Churchill Hospital | Churchill Hospital, Oxford, UK | Churchill Hospital, Oxford, United Kingdom | Clinical Trial Service Unit (CTSU), University of Oxford | Clinical Trial Service Unit & Epidemiological Studies Unit, University of Oxford | Clinical Trial service Unit, University of Oxford | Clinical Trial Service Unit, University of Oxford | Department of Cardiovascular Medicine, John Radcliffe Hospital, University of Oxford | Department of Oncology, University of Oxford | Department of Paediatrics, Oxford University | Department of Psychiatry, University of Oxford | Dept. Clinical Immunology, Oxford Radcliffe Hospitals | Dept. Psychiatry, University of Oxford | Diabetes Trials Unit, University of Oxford | Director, The Jenner Institute, Oxford University | Dr Paola Cicconi | Eijkman-Oxford Clinical Research Unit, Oxford University | Global Health - Oxford University Siena University | Jenner Institute | Jenner Institute, University of Oxford | John Radcliffe Hospital, Oxford, UK | KEMRI Centre for Geographic Medicine Research (Coast), University of Oxford, England | KEMRI Wellcome Trust Research Programme and University of Oxford | KEMRI-Wellcome Trust Research Programme, University of Oxford | KEMRI/Wellcome Trust Research Programme & University of Oxford | Lao-Oxford-Mahosot Hospital Wellcome Trust Research Unit | Lao-Oxford-Mahosot Hospital Wellcome Trust Research Unit (LOMWRU) | Lao-Oxford-Mahosot Hospital Wellcome Trust Research Unit (LOMWRU), Laos | Medical Research Council Population Health Research Unit, CTSU, University of Oxford (academic lead) | Mountain Medicine Society of Nepal (MMSN), Nepal International Clinic (NIC) and Oxford University Clinical Research Unit (OUCRU), Kathmandu, Nepal | MRC Human Immunology Unit, John Radcliffe Hospital, University of Oxford, OX3 9DS UK | NDORMS, University of Oxford | NHS Blood and Transplant, Oxford, United Kingdom | Nuffield Department of Clinical Neurosciences | Nuffield Department of Clinical Neurosciences, Oxford (UOXF) | Nuffield Department of Medicine, University of Oxford, UK | Nuffield Department of Obstetrics and Gynaecology, University of Oxford | Nuffield Dept of Clinical Medicine, University of Oxford | Oxford Cancer & Haematology Centre, The Churchill Hospital, Old Road - Headington, Oxford, OX3 7LE Email: ronjon.chakraverty@ndcls.ox.ac.uk | Oxford Centre for Enablement, Oxford University Hospitals NHS FT, Windmill Road, Oxford OX3 7HE, United Kingdom | Oxford Clinical Trials Research Unit | Oxford Clinical Trials Research Unit (OCTRU) | Oxford-Emergent Tuberculosis Consortium | Oxford Eye Hospital | Oxford Haemophilic Centre and Thrombosis Unit, Churchill Hospital | Oxford Health NHS Foundation Trust | Oxford Radcliffe Hospitals Trust | Oxford Radcliffe NHS Trust & University of Oxford | Oxford Radcliffe NHS Trust, University of Oxford | Oxford Radclifffe Hospitals NHS Trust | Oxford Research | Oxford University | Oxford University Clinical Research Unit | Oxford University Clinical Research Unit Indonesia | Oxford University Clinical Research Unit, Vietnam | Oxford University Hospital NHS Trust | Oxford University Hospitals | Oxford University Hospitals NHS Trust | Oxford University Hospitals Trust | Oxford University Hospitals Trust, John Radcliffe Hospital, Oxford, UK, | Oxford University, KEMRI-Wellcome Trust | Oxford University of Clinical Research | Oxford University, UK | Oxford Vaccine Group | Oxford Vaccine Group, Centre for Clinical Vaccinology and Tropical Medicine (CCVTM), Churchill Hospital | Oxford Vaccine Group, Centre for Clinical Vaccinology and Tropical Medicine, Churchill Hospital, Oxford OX3 7LJ | Oxford Vaccine Group, Chief Investigator | Oxford Vaccine Group, Department of Paediatrics, University of Oxford | Oxford Vaccine Group, The University of Oxford | Oxford Vaccine Group, University of Oxford | Pain Research & Nuffield Department of Anaesthetics - University of Oxford | Pain Research & Nuffield Division of Anaesthesics, Department of Clinical Neurosciences, University of Oxford. The Churchill, Oxford OX3 7LJ (United Kingdom) | The Churchill Hospital, Oxford, UK | The Jenner Institute, University of Oxford | The Oxford University Hospitals NHS Trust | The University of Oxford | Univeristy of Oxford | Universitiy of Oxford & Kenya Medical Research Institute | University of Oxford | University of Oxford and Oxford Radcliffe NHS Trust | University of Oxford (at the time of study); MRC Cognition and Brain Sciences unit (current) | University of Oxford; Centre for Vaccinology & Tropical Medicine | University of Oxford, Clinical Vaccine Research and Immunisation Education | University of Oxford Department of Oncology, Churchill Hospital | University of Oxford, Department of Paediatrics | University of Oxford. Department of Paediatrics | University of Oxford, Departmentof Psychiatry, UK | University of Oxford, John Radcliffe Hospital | University of Oxford & KEMRI-Wellcome Trust | University of Oxford, Medical Sciences Division, Department of Psychiatry | University of Oxford, Oxford Radcliffe Hospitals NHS Trust and Moorfields Eye Hospital | University of Oxford, UK | Warneford Hospital, Oxford | Wellcome Centre for Integrative Neuroimaging
Highest phase reached
Phase 4
First clinical trial
Sep 1, 1983Last known activity
Feb 20, 2026
Timeline
1090s
- Jan 1, 1096
University of Oxford— Founded
Drugs by trial phase (539 distinct, 624 trials)
Phase 4 (114 own, 0 via acquisition)
Phase 3 (81 own, 0 via acquisition)
Phase 2 (202 own, 0 via acquisition)
Phase 1 (66 own, 0 via acquisition)
Other trials (76 own, 0 via acquisition)
Indications
Studied for
- Abortion, Missed
- Abortion, Spontaneous
- ACTH-Secreting Pituitary Adenoma
- Acute Coronary Syndrome
- Acute Pain
- Adenocarcinoma
- Altitude Sickness
- Alzheimer Disease
- Amyloidosis
- Anemia
- Anemia, Iron-Deficiency
- Aphasia, Primary Progressive
- Arachnodactyly
- Arthritis
- Arthritis, Psoriatic
- Asthma
- Atherosclerosis
- Atrial Fibrillation
- Autoimmune Diseases
- Bacterial Infections
- Barrett Esophagus
- Bipolar Disorder
- Breast Neoplasms
- Carcinoma
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Ovarian Epithelial
- Carcinoma, Renal Cell
- Carcinoma, Squamous Cell
- Cardiomyopathies
- Cardiomyopathy, Hypertrophic
- Cardiovascular Diseases
- Cerebral Small Vessel Diseases
- Cerebrovascular Disorders
- Chemical and Drug Induced Liver Injury
- Chikungunya Fever
- Child Nutrition Disorders
- Choroideremia
- Chronic Disease
- Chylothorax
- Coccidioidomycosis
- Coccidiosis
- Cognitive Dysfunction
- Colitis
- Colitis, Ulcerative
- Colonic Neoplasms
- Colorectal Neoplasms
- Communicable Diseases
- Constipation
- Coronary Artery Disease
- Coronary Disease
- Coronavirus Infections
- Cough
- Critical Illness
- Crohn Disease
- Cross Infection
- Cushing Syndrome
- Cystic Fibrosis
- Dementia
- Dengue
- Depression
- Depressive Disorder
- Depressive Disorder, Treatment-Resistant
- Diabetes Mellitus
- Diabetes Mellitus, Type 1
- Diabetes Mellitus, Type 2
- Diabetic Retinopathy
- Diarrhea
- Disease
- Dupuytren Contracture
- Dysentery
- Dysentery, Bacillary
- Dyspnea
- Eclampsia
- Edema
- Encephalitis
- Endocrine System Diseases
- Endometriosis
- Epilepsy
- Esophageal Neoplasms
- Fallopian Tube Neoplasms
- Fatigue
- Fatty Liver
- Fever
- Fibrosis
- Foot-and-Mouth Disease
- Frontotemporal Dementia
- Glucose Intolerance
- Glucosephosphate Dehydrogenase Deficiency
- Hand, Foot and Mouth Disease
- Headache
- Heart Diseases
- Heart Failure
- Helminthiasis
- Hematologic Neoplasms
- Hemophilia A
- Hemorrhage
- Hemorrhagic Fever, Ebola
- Hepatitis
- Hepatitis A
- Hepatitis B
Recent trials (50)
- NCT06978062OfficialPhase 1Feb 20, 2026
- NCT07309614CollaboratorPhase 3Jan 31, 2026
- NCT07168018Lead sponsorPhase 2Dec 31, 2025
- NCT07168018OfficialPhase 2Dec 31, 2025
- NCT07194668Lead sponsorPhase 4Dec 1, 2025
- NCT07183371Lead sponsorPhase 2Nov 30, 2025
- NCT07074665Lead sponsorPhase 2Oct 31, 2025
- NCT07267559Lead sponsorPhase 4Oct 1, 2025
- NCT07267559OfficialPhase 4Oct 1, 2025
- NCT06958198Lead sponsorPhase 1Sep 15, 2025
- NCT07054931Lead sponsorPhase 2Sep 5, 2025
- NCT06551844Lead sponsorPhase 2Sep 1, 2025
- NCT06551844OfficialPhase 2Sep 1, 2025
- NCT07017023Lead sponsorEarly Phase 1Jul 8, 2025
- NCT07017023OfficialEarly Phase 1Jul 8, 2025
Details
- Founded
- Oxford, England, GB Jan 1, 1096
- Last known activity
- Feb 20, 2026